Scholars@Duke

Should DDGP Regimen Be the Standard of Care for Advanced Extranodal NK/T-Cell Lymphoma? The New Staging System Matters-Reply.

Publication ,  Journal Article
Wang, X; Young, KH; Zhang, M
Published in: JAMA Oncol
February 1, 2023
Published version (DOI) Link to item

Duke Scholars

Ken H Young
Author Ken H Young Pathology
Altmetric Attention Stats
Dimensions Citation Stats

Published In

JAMA Oncol

DOI

10.1001/jamaoncol.2022.6463

EISSN

2374-2445

Publication Date

February 1, 2023

Volume

9

Issue

2

Start / End Page

279 / 280

Location

United States

Related Subject Headings

  • Standard of Care
  • Lymphoma, Extranodal NK-T-Cell
  • Humans
  • Gemcitabine
  • 3211 Oncology and carcinogenesis
  • 1117 Public Health and Health Services
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wang, X., Young, K. H., & Zhang, M. (2023). Should DDGP Regimen Be the Standard of Care for Advanced Extranodal NK/T-Cell Lymphoma? The New Staging System Matters-Reply. JAMA Oncol, 9(2), 279–280. https://doi.org/10.1001/jamaoncol.2022.6463
Wang, Xinhua, Ken H. Young, and Mingzhi Zhang. “Should DDGP Regimen Be the Standard of Care for Advanced Extranodal NK/T-Cell Lymphoma? The New Staging System Matters-Reply.” JAMA Oncol 9, no. 2 (February 1, 2023): 279–80. https://doi.org/10.1001/jamaoncol.2022.6463.
Wang, Xinhua, et al. “Should DDGP Regimen Be the Standard of Care for Advanced Extranodal NK/T-Cell Lymphoma? The New Staging System Matters-Reply.” JAMA Oncol, vol. 9, no. 2, Feb. 2023, pp. 279–80. Pubmed, doi:10.1001/jamaoncol.2022.6463.

Published In

JAMA Oncol

DOI

10.1001/jamaoncol.2022.6463

EISSN

2374-2445

Publication Date

February 1, 2023

Volume

9

Issue

2

Start / End Page

279 / 280

Location

United States

Related Subject Headings

  • Standard of Care
  • Lymphoma, Extranodal NK-T-Cell
  • Humans
  • Gemcitabine
  • 3211 Oncology and carcinogenesis
  • 1117 Public Health and Health Services
  • 1112 Oncology and Carcinogenesis